Capital Advisory Group Advisory Services, LLC Ironwood Pharmaceuticals Inc Transaction History

Capital Advisory Group Advisory Services, LLC

$233 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 15, 2022	SELL	$10.86 - $13.95 $1,552 - $1,994	-143 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $1,704 - $1,990	143 New	143 $2,000

Others Institutions Holding IRWD

# of Institutions

246

Shares Held

171M

Call Options Held

11.2M

Put Options Held

28.5K

Black Rock Inc. New York, NY

22.9M
Shares

$96.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

21.6M
Shares

$91.2 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$69.3 Million
18.04% of portfolio
State Street Corp Boston, MA

9.24M
Shares

$39.1 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

8.91M
Shares

$37.7 Million
0.15% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $648M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account